2020?ê12??19è?£??ò?o??ó¢?ìêúí??óáao?Emory′ó?§ò??????ìêú£??úò??§-?ú·??úó?′úD?áìóòTOP?ú?ˉMolecular Metabolism£¨1??£?IF5=7.118£??ú??·¢±íá?ìa?a?°Crosstalk between the muscular estrogen receptor |á and BDNF/TrkB signaling alleviates metabolic syndrome via 7,8-dihydroxyflavone in female mice?±μ??D???????£???D??ê×′??òê?á?7,8-DHF?ú±£?¤??D????e??-′1ì?-??32éú?3?á1|?üoí?¤??×é?ˉì?òìD?ER|á·???μ?D?×÷ó?£??° 7,8-DHF×÷ó???1?÷à??ER|áoíBDNF/TrkBD?o?′?è?μ÷??1?÷à???üá?′úD?μ?1??ü×÷ó??°?ú???£?óé?á???7,8-DHF?ú??é?′úD?×?o??÷?D±í??3?μ?D?±e2?òìμ?è?ê?£??a??D?′úD??é?ò?à1??22?μ?·à??£¨óè??ê????-oó??D?£?ìá1?á?D?μ????·oí·?·¨?£
?
?D??±3?°£o
7,8-?t???ù??ía£¨7,8-dihydroxyflavone£?7,8-DHF£?×÷?a×?è????Dììè?′??úμ?ò??????ao±??μ???íaàà?ˉo???£??é×÷?a?-???òμ°°×êüì??¤?? B£¨TrkB£?μ?ì?òìD?D?·?×ó?¤?ˉ?á£??ü?£?a???′D?é??-óa(chǎn)??òò×ó£¨BDNF£?μ?1|?ü£???ò?2??¤?? TrkB ??ó?μ?D?o?í¨?·?£2015?êò?????μè?D??·¢??7,8-DHF?éí¨1y?¤??1?÷à??TrkB?o?a′?êóòò????ò?ê3ó?μ?μ?·ê??£?2¢3ê??3?????μ?D?±e2?òì?£è???£??a??D?±e2?òìμ??±?ú·?×ó×÷ó??ú??éD2???3t?£′?ía£?′óá??D???òê?′??¤??oí′??¤??êüì??ú?úì?′úD?μ÷???D?e×???òa×÷ó??£???-oóμ???D?£?1?÷à??′??¤??êüì?ER|á1|?üêü?e£??üò×??′úD?×?o??÷(MetS)?£òò′?£?±??D?????úì?ì?1?÷à??ER|áê?·?2?ó?á?7,8-DHF??′?D?MetSμ?μ÷??£?ò??òê?7,8-DHFD?±e2?òìD?μ÷??MetSμ??±?ú·?×ó?ú???£
?D??·?·¨£o
?D??è??±2éó?8?üá?C57BL/6J′?D?D?êó£¨72??£?£?·?±e??óè10%μí??oí60%??????á??1??£?í?ê±??óèèü?á?????òμí?¢?D?¢??èy??2?í??áá?7,8-DHF1à??£?ê±??3¤′?°??ê£??ú????D?êóì????¢é?ê3á?£?ò??°·¢?é?ü?ú??DD?ü?D?à2a?£??oó£??????e??-′1ì?-??32£¨hypothalamic-pituitary-ovarian, HPO£??áμ?1|?ü??DDá??à1à£??ì2aá?óD′ú±íD?μ??a??D??¤??ò??°??32′¢±??à1??¤??????£?2éó?2?àíá?D??D??·?·¨?à1à??32′¢±??é???£′?ía£???′úD?×?o??÷μ??÷????±êò2??DDá??ì2a£?°üà¨ì????¢ì???·?2??°o?á?£¨?ú?à??·??¢?¤????·?£??¢??′úD??¢??ì?ì?/òèμo???íêü?¢1??ü?è?¢???1?aì?/?aòèμo??o?á?ò??°?°?×?¢??°?òò×óμè?£í?ê±?ì2a1?÷à???°°×é???·?×é?ˉ?DER|á?°?üá?′úD??à1?D?o?·?×ó?ùòò?°μ°°×????μ?±í′??£ì?íaêμ?é2éó??????ˉ?§ò????áoí?y2????ì·¢?DRNA×aè???3y2???£??ú·??ˉμ?C2C12??1ü?D?é?¤á?2?ó?ER|áoíBDNF/TrkBD?o?í¨?·′?è?μ?·?×ó?ú???£
?
??? ??òa?á1?£o
?á1?·¢??£?3¤?ú7,8-DHF?é?¤??′?êóHPO?á1|?üóD????μ?±£?¤×÷ó?£??é?ó?o??32?¥??oíìá?°???-£?2¢??3??ú·??ú?à1?D??¤???????è?¨?£2¢?ò£?D?êóòò????ò?ê3?òéú?3?á?ú·??ú?é?òμ???μ?′úD?×?o??÷?÷????±ê?ùμ?μ?óDD§??é??£7,8-DHF?é?¤?ü1?????é?μ÷1?÷à???DER|á ?ùòòoíμ°°×????μ?±í′?£????ó?a??áaμ°°×1£¨UCP1£?μ°°×±í′?????£?2¢í?ê±?¤??1?÷à???DBDNF/TrkB?°??ó??üá?′úD??à1?D?o?í¨?·?£7,8-DHF??ER|á?ú??°±?á118£¨S118£?oíàò°±?á537£¨Y537£?μ?·′ê??¤??ê?BDNF/TrkBD?o???áa?¤??μ?1??ü?£·′1yà′£?BDNF/TrkBD?o???áaμ??¤??ò2ê?ER|á?úá???á×?á?ˉ??μ??¤???ù±?Dèμ?£?óè??ê??úY537á×?á?ˉ??μ?£?2¢?ò·¢??£?Srcμ°°×?¤???ò×??úER|áoíBDNF/TrkBD?o?′?è??D?eo?D?×÷ó?£?D-í??¤??ó??üá?′úD??à1?μ?D?o?í¨?·?£×?é?£?7,8-DHF?éí¨1y±£?¤′?D?éú?3?á1|?ü£?ò???3?D??¤???à1??ú·??ú?èì?£?2¢í¨1y1?÷à??′??¤??êüì?ER|áoíBDNF/TrkBD?o?′?è?12í?×÷ó?óú??′?D?′úD?×?o??÷μ???é??£
???
?
??????μúò?×÷???a?ò?oê3?·???§×¨òμ?ú?á2?ê??D??éú???òà×£?í¨??×÷???a?ò?o??ó¢?ìêúoí?à1úEmory′ó?§ò??????ìêú£????-′ó?§?aμúò?êe??μ¥???£????2?·?1¤×÷μ?μ?1???ê???μ??D·¢????μ?×ê?ú?£
?-??á′?ó£ohttps://doi.org/10.1016/j.molmet.2020.101149
?
éú???μí31¤3ìó?ê3?·???§?§?o
2020?ê12??25è?
?
版權(quán)與免責(zé)聲明:本網(wǎng)頁的內(nèi)容由收集互聯(lián)網(wǎng)上公開發(fā)布的信息整理獲得。目的在于傳遞信息及分享,并不意味著贊同其觀點(diǎn)或證實(shí)其真實(shí)性,也不構(gòu)成其他建議。僅提供交流平臺,不為其版權(quán)負(fù)責(zé)。如涉及侵權(quán),請聯(lián)系我們及時修改或刪除。郵箱:sales@allpeptide.com